IDYA
Price
$32.17
Change
+$0.40 (+1.26%)
Updated
Feb 6 closing price
Capitalization
2.82B
51 days until earnings call
Intraday BUY SELL Signals
KURA
Price
$7.83
Change
+$0.43 (+5.81%)
Updated
Feb 6 closing price
Capitalization
681.35M
23 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IDYA vs KURA

Header iconIDYA vs KURA Comparison
Open Charts IDYA vs KURABanner chart's image
IDEAYA Biosciences
Price$32.17
Change+$0.40 (+1.26%)
Volume$985.32K
Capitalization2.82B
Kura Oncology
Price$7.83
Change+$0.43 (+5.81%)
Volume$1.54M
Capitalization681.35M
IDYA vs KURA Comparison Chart in %
IDYA
Daily Signal:
Gain/Loss:
KURA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IDYA vs. KURA commentary
Feb 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Hold and KURA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 09, 2026
Stock price -- (IDYA: $32.17 vs. KURA: $7.83)
Brand notoriety: IDYA and KURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 106% vs. KURA: 100%
Market capitalization -- IDYA: $2.82B vs. KURA: $681.35M
IDYA [@Biotechnology] is valued at $2.82B. KURA’s [@Biotechnology] market capitalization is $681.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 1 FA rating(s) are green whileKURA’s FA Score has 1 green FA rating(s).

  • IDYA’s FA Score: 1 green, 4 red.
  • KURA’s FA Score: 1 green, 4 red.
According to our system of comparison, both IDYA and KURA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 3 TA indicator(s) are bullish while KURA’s TA Score has 4 bullish TA indicator(s).

  • IDYA’s TA Score: 3 bullish, 7 bearish.
  • KURA’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, KURA is a better buy in the short-term than IDYA.

Price Growth

IDYA (@Biotechnology) experienced а -0.06% price change this week, while KURA (@Biotechnology) price change was -3.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.30%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was +31.79%.

Reported Earning Dates

IDYA is expected to report earnings on Mar 31, 2026.

KURA is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (-2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($2.82B) has a higher market cap than KURA($681M). IDYA YTD gains are higher at: -6.942 vs. KURA (-24.639). IDYA (-204.84M) and KURA (-212.24M) have comparable annual earnings (EBITDA) . IDYA has more cash in the bank: 787M vs. KURA (550M). KURA has less debt than IDYA: KURA (19.5M) vs IDYA (27.2M). IDYA has higher revenues than KURA: IDYA (215M) vs KURA (104M).
IDYAKURAIDYA / KURA
Capitalization2.82B681M414%
EBITDA-204.84M-212.24M97%
Gain YTD-6.942-24.63928%
P/E RatioN/AN/A-
Revenue215M104M207%
Total Cash787M550M143%
Total Debt27.2M19.5M139%
FUNDAMENTALS RATINGS
IDYA vs KURA: Fundamental Ratings
IDYA
KURA
OUTLOOK RATING
1..100
6659
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
67100
SMR RATING
1..100
9498
PRICE GROWTH RATING
1..100
5263
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IDYA's Valuation (50) in the null industry is in the same range as KURA (50) in the Biotechnology industry. This means that IDYA’s stock grew similarly to KURA’s over the last 12 months.

IDYA's Profit vs Risk Rating (67) in the null industry is somewhat better than the same rating for KURA (100) in the Biotechnology industry. This means that IDYA’s stock grew somewhat faster than KURA’s over the last 12 months.

IDYA's SMR Rating (94) in the null industry is in the same range as KURA (98) in the Biotechnology industry. This means that IDYA’s stock grew similarly to KURA’s over the last 12 months.

IDYA's Price Growth Rating (52) in the null industry is in the same range as KURA (63) in the Biotechnology industry. This means that IDYA’s stock grew similarly to KURA’s over the last 12 months.

IDYA's P/E Growth Rating (100) in the null industry is in the same range as KURA (100) in the Biotechnology industry. This means that IDYA’s stock grew similarly to KURA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDYAKURA
RSI
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 4 days ago
81%
MACD
ODDS (%)
Bearish Trend 3 days ago
82%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 18 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
80%
Aroon
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
IDYA
Daily Signal:
Gain/Loss:
KURA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LICOX19.930.56
+2.89%
Lord Abbett International Equity F3
AMEIX36.080.70
+1.98%
American Century Equity Growth I
NUGAX35.370.65
+1.87%
Nuveen Global Dividend Growth A
VGRTX89.411.38
+1.57%
JPMorgan US Value R2
PIUIX9.48N/A
N/A
Federated Hermes International Equity IS

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been closely correlated with IMNM. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if IDYA jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+1.26%
IMNM - IDYA
68%
Closely correlated
+3.67%
NRIX - IDYA
67%
Closely correlated
+5.64%
IMVT - IDYA
66%
Loosely correlated
+12.43%
NUVL - IDYA
65%
Loosely correlated
+2.67%
SYRE - IDYA
65%
Loosely correlated
+6.62%
More

KURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KURA has been loosely correlated with PYXS. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if KURA jumps, then PYXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KURA
1D Price
Change %
KURA100%
+5.81%
PYXS - KURA
62%
Loosely correlated
-1.95%
NRIX - KURA
56%
Loosely correlated
+5.64%
IMNM - KURA
53%
Loosely correlated
+3.67%
IDYA - KURA
52%
Loosely correlated
+1.26%
SNDX - KURA
52%
Loosely correlated
+4.27%
More